Accès gratuit
Numéro
Réanimation
Volume 25, Numéro 3, Mai 2016
Infectieux
Page(s) 328 - 339
Section Mise Au Point / Update
DOI https://doi.org/10.1007/s13546-016-1196-1
Publié en ligne 14 avril 2016
  • Isakow W, Morrow LE, Kollef MH (2007) Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations. Chest 132:286–94 [CrossRef] [PubMed] [Google Scholar]
  • McNabb B, Isakow W (2008) Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions. Curr Opin Pulm Med 14:168–75 [CrossRef] [PubMed] [Google Scholar]
  • Lilly DM, Stillwell RH (1965) Probiotics: growth-promoting factors produced by microorganisms. Science 147:747–8 [CrossRef] [PubMed] [Google Scholar]
  • Guidelines for the evaluation of probiotics in food: report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf [Google Scholar]
  • Morrow LE, Kollef MH (2008) Probiotics in the intensive care unit: why controversies and confusion abound. Crit Care 12:160 [CrossRef] [PubMed] [Google Scholar]
  • Gareau MG, Sherman PM, Walker WA (2010) Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7:503–14 [CrossRef] [PubMed] [Google Scholar]
  • Butel MJ (2014) Probiotics, gut microbiota and health. Med Mal Infect 44:1–8 [CrossRef] [PubMed] [Google Scholar]
  • Sertaridou E, Papaioannou V, Kolios G, Pneumatikos I (2015) Gut failure in critical care: old school versus new school. Ann Gastroenterol 28:309–22 [PubMed] [Google Scholar]
  • Macpherson AJ, Harris NL (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4:478–85 [CrossRef] [PubMed] [Google Scholar]
  • Mittal R, Coopersmith CM (2014) Redefining the gut as the motor of critical illness. Trends Mol Med 20:214–23 [CrossRef] [PubMed] [Google Scholar]
  • Sekirov I, Russell SL, Antunes LCM, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90:859–904 [CrossRef] [PubMed] [Google Scholar]
  • Brestoff JR, Artis D (2013) Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 14:676–84 [CrossRef] [PubMed] [Google Scholar]
  • Brown EM, Sadarangani M, Finlay BB (2013) The role of the immune system in governing host-microbe interactions in the intestine. Nat Immunol 14:660–7 [CrossRef] [PubMed] [Google Scholar]
  • Donaldson GP, Lee SM, Mazmanian SK (2016) Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14:20–32 [CrossRef] [PubMed] [Google Scholar]
  • Huang YJ, Charlson ES, Collman RG, et al (2013) The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. Am J Respir Crit Care Med 187:1382–7 [CrossRef] [PubMed] [Google Scholar]
  • Zeissig S, Blumberg RS (2014) Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease. Nat Immunol 15:307–10 [CrossRef] [PubMed] [Google Scholar]
  • Maslowski KM, Mackay CR (2011) Diet, gut microbiota and immune responses. Nat Immunol 12:5–9 [CrossRef] [PubMed] [Google Scholar]
  • Pamer EG (2007) Immune responses to commensal and environmental microbes. Nat Immunol 8:1173–8 [CrossRef] [PubMed] [Google Scholar]
  • Bäckhed F, Ley RE, Sonnenburg JL, et al (2005) Host-bacterial mutualism in the human intestine. Science 307:1915–20 [CrossRef] [PubMed] [Google Scholar]
  • Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336:1268–73 [CrossRef] [PubMed] [Google Scholar]
  • Kamada N, Chen GY, Inohara N, Núñez G (2013) Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 14:685–90 [CrossRef] [PubMed] [Google Scholar]
  • Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9:313–23 [CrossRef] [PubMed] [Google Scholar]
  • Chu H, Mazmanian SK (2013) Innate immune recognition of the microbiota promotes host-microbial symbiosis. Nat Immunol 14:668–75 [CrossRef] [PubMed] [Google Scholar]
  • West CE, Renz H, Jenmalm MC, et al (2015) The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. J Allergy Clin Immunol 135:3–13 [CrossRef] [PubMed] [Google Scholar]
  • Hayakawa M, Asahara T, Henzan N, et al (2011) Dramatic changes of the gut flora immediately after severe and sudden insults. Dig Dis Sci 56:2361–5 [CrossRef] [PubMed] [Google Scholar]
  • Shimizu K, Ogura H, Hamasaki T, et al (2011) Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig Dis Sci 56:1171–7 [CrossRef] [PubMed] [Google Scholar]
  • Kanazawa H, Nagino M, Kamiya S, et al (2005) Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 390:104–13 [CrossRef] [PubMed] [Google Scholar]
  • Gatt M, Reddy BS, MacFie J (2007) Review article: bacterial translocation in the critically ill — evidence and methods of prevention. Aliment Pharmacol Ther 25:741–57 [CrossRef] [PubMed] [Google Scholar]
  • Alexandre Y, Le Blay G, Boisramé-Gastrin S, et al (2014) Probiotics: a new way to fight bacterial pulmonary infections? Med Mal Infect 44:9–17 [CrossRef] [PubMed] [Google Scholar]
  • Hill C, Guarner F, Reid G, et al (2014) Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–14 [CrossRef] [PubMed] [Google Scholar]
  • Klarin B, Johansson ML, Molin G, et al (2005) Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Crit Care 9:R285–R93 [CrossRef] [PubMed] [Google Scholar]
  • Tan M, Zhu JC, Du J, et al (2011) Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study. Crit Care 15:R290 [CrossRef] [PubMed] [Google Scholar]
  • McNaught CE, Woodcock NP, Anderson ADG, MacFie J (2005) A prospective randomised trial of probiotics in critically ill patients. Clin Nutr Edinb Scotl 24:211–9 [CrossRef] [Google Scholar]
  • Alberda C, Gramlich L, Meddings J, et al (2007) Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 85:816–23 [CrossRef] [PubMed] [Google Scholar]
  • Barraud D, Blard C, Hein F, et al (2010) Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med 36:1540–7 [CrossRef] [PubMed] [Google Scholar]
  • Jain PK, McNaught CE, Anderson ADG, et al (2004) Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr Edinb Scotl 23:467–75 [CrossRef] [Google Scholar]
  • Morrow LE, Kollef MH, Casale TB (2010) Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 182:1058–64 [CrossRef] [PubMed] [Google Scholar]
  • Oudhuis GJ, Bergmans DC, Dormans T, et al (2011) Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality. Intensive Care Med 37:110–7 [CrossRef] [PubMed] [Google Scholar]
  • Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, et al (2006) Benefits of a synbiotic formula (Synbiotic 2000Forte®) in critically Ill trauma patients: early results of a randomized controlled trial. World J Surg 30:1848–55 [CrossRef] [PubMed] [Google Scholar]
  • Spindler-Vesel A, Bengmark S, Vovk I, et al (2007) Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. JPEN J Parenter Enteral Nutr 31:119–26 [CrossRef] [PubMed] [Google Scholar]
  • Knight DJW, Gardiner D, Banks A, et al (2009) Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med 35:854–61 [CrossRef] [PubMed] [Google Scholar]
  • Rayes N, Seehofer D, Hansen S, et al (2002) Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74:123–7 [CrossRef] [PubMed] [Google Scholar]
  • Rayes N, Seehofer D, Theruvath T, et al (2005) Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation — a randomized, double-blind trial. Am J Transplant 5:125–30 [CrossRef] [PubMed] [Google Scholar]
  • Forestier C, Guelon D, Cluytens V, et al (2008) Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care 12:R69 [CrossRef] [PubMed] [Google Scholar]
  • Sanaie S, Ebrahimi-Mameghani M, Hamishehkar H, et al (2014) Effect of a multispecies probiotic on inflammatory markers in critically ill patients: a randomized, double-blind, placebo-controlled trial. J Res Med Sci 19:827–33 [PubMed] [Google Scholar]
  • Besselink MGH, van Santvoort HC, Buskens E, et al (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371:651–9 [CrossRef] [PubMed] [Google Scholar]
  • Siempos II, Ntaidou TK, Falagas ME (2010) Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 38:954–62 [CrossRef] [PubMed] [Google Scholar]
  • Liu K, Zhu Y, Zhang J, et al (2012) Probiotics’ effects on the incidence of nosocomial pneumonia in critically ill patients: a systematic review and meta-analysis. Crit Care 16:R109 [CrossRef] [PubMed] [Google Scholar]
  • Gu WJ, Wei CY, Yin RX (2012) Lack of efficacy of probiotics in preventing ventilator-associated pneumonia probiotics for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. Chest 142:859–68 [CrossRef] [PubMed] [Google Scholar]
  • Barraud D, Bollaert PE, Gibot S (2013) Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials. Chest 143:646–55 [CrossRef] [PubMed] [Google Scholar]
  • Doron S, Snydman DR (2015) Risk and safety of probiotics. Clin Infect Dis 60:S129–S34 [CrossRef] [PubMed] [Google Scholar]
  • Bo L, Li J, Tao T, et al (2014) Probiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst Rev 10:CD009066 [PubMed] [Google Scholar]
  • Forsythe P (2014) Probiotics and lung immune responses. Ann Am Thorac Soc 11:S33–S7 [CrossRef] [PubMed] [Google Scholar]
  • Li J, Jia H, Cai X, et al (2014) An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 32:834–41 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.